Company registration number SC725819 (Scotland)
THE ALBION CLINIC LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025
PAGES FOR FILING WITH REGISTRAR
THE ALBION CLINIC LIMITED
CONTENTS
Page
Balance sheet
1 - 2
Notes to the financial statements
3 - 6
THE ALBION CLINIC LIMITED
BALANCE SHEET
AS AT
31 MARCH 2025
31 March 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Intangible assets
3
847,700
968,800
Tangible assets
4
23,725
24,657
871,425
993,457
Current assets
Stocks
7,950
7,950
Debtors
5
115,576
104,206
Cash at bank and in hand
6,782
19,047
130,308
131,203
Creditors: amounts falling due within one year
6
(321,176)
(687,615)
Net current liabilities
(190,868)
(556,412)
Total assets less current liabilities
680,557
437,045
Provisions for liabilities
(5,931)
(6,164)
Net assets
674,626
430,881
Capital and reserves
Called up share capital
7
100
100
Profit and loss reserves
674,526
430,781
Total equity
674,626
430,881
THE ALBION CLINIC LIMITED
BALANCE SHEET (CONTINUED)
AS AT
31 MARCH 2025
31 March 2025
- 2 -

For the financial year ended 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

T he members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved and signed by the director and authorised for issue on 14 November 2025
Mr A J Mee
Director
Company registration number SC725819 (Scotland)
THE ALBION CLINIC LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025
- 3 -
1
Accounting policies
Company information

The Albion Clinic Limited is a private company limited by shares incorporated in Scotland. The registered office is 211 Albion Street, Glasgow, United Kingdom, G1 1RU.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, [modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value]. The principal accounting policies adopted are set out below.

1.2
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business,

1.3
Intangible fixed assets - goodwill

Goodwill represents the excess of the cost of acquisition of unincorporated businesses over the fair value of net assets acquired. It is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is considered to have a finite useful life and is amortised on a systematic basis over its expected life, which is 10 years.

1.4
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Plant and equipment
25% on reducing balance
Fixtures and fittings
25% on reducing balance

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.5
Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.

1.6
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

THE ALBION CLINIC LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
1
Accounting policies
(Continued)
- 4 -
1.7
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

1.8
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
12
9
THE ALBION CLINIC LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 5 -
3
Intangible fixed assets
Goodwill
£
Cost
At 1 April 2024 and 31 March 2025
1,211,000
Amortisation and impairment
At 1 April 2024
242,200
Amortisation charged for the year
121,100
At 31 March 2025
363,300
Carrying amount
At 31 March 2025
847,700
At 31 March 2024
968,800
4
Tangible fixed assets
Plant and equipment
Fixtures and fittings
Total
£
£
£
Cost
At 1 April 2024
28,795
9,000
37,795
Additions
4,999
-
0
4,999
At 31 March 2025
33,794
9,000
42,794
Depreciation and impairment
At 1 April 2024
9,898
3,240
13,138
Depreciation charged in the year
4,779
1,152
5,931
At 31 March 2025
14,677
4,392
19,069
Carrying amount
At 31 March 2025
19,117
4,608
23,725
At 31 March 2024
18,897
5,760
24,657
5
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
113,666
101,758
Prepayments and accrued income
1,910
2,448
115,576
104,206
THE ALBION CLINIC LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 6 -
6
Creditors: amounts falling due within one year
2025
2024
£
£
Corporation tax
121,101
109,465
Other taxation and social security
5,037
4,529
Other creditors
116,429
511,410
Accruals and deferred income
78,609
62,211
321,176
687,615
7
Called up share capital
2025
2024
2025
2024
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary A shares of £1 each
50
100
50
50
Ordinary B shares of £1 each
50
50
50
50
100
150
100
100
8
Related party transactions

At the year end 31 March 2025, the company owed the director £115,155 (2024 - £510,426).

The loan is unsecured, interest free and repayable on demand.

2025-03-31 2024-04-01 false false false 14 November 2025 CCH Software CCH Accounts Production 2025.300 No description of principal activity Mr A J Mee SC725819 2024-04-01 2025-03-31 SC725819 2025-03-31 SC725819 2024-03-31 SC725819 core:NetGoodwill 2025-03-31 SC725819 core:NetGoodwill 2024-03-31 SC725819 core:PlantMachinery 2025-03-31 SC725819 core:FurnitureFittings 2025-03-31 SC725819 core:PlantMachinery 2024-03-31 SC725819 core:FurnitureFittings 2024-03-31 SC725819 core:WithinOneYear 2025-03-31 SC725819 core:WithinOneYear 2024-03-31 SC725819 core:CurrentFinancialInstruments 2025-03-31 SC725819 core:CurrentFinancialInstruments 2024-03-31 SC725819 core:ShareCapital 2025-03-31 SC725819 core:ShareCapital 2024-03-31 SC725819 core:RetainedEarningsAccumulatedLosses 2025-03-31 SC725819 core:RetainedEarningsAccumulatedLosses 2024-03-31 SC725819 core:ShareCapitalOrdinaryShareClass1 2025-03-31 SC725819 core:ShareCapitalOrdinaryShareClass1 2024-03-31 SC725819 core:ShareCapitalOrdinaryShareClass2 2025-03-31 SC725819 core:ShareCapitalOrdinaryShareClass2 2024-03-31 SC725819 core:ShareCapitalOrdinaryShares 2025-03-31 SC725819 core:ShareCapitalOrdinaryShares 2024-03-31 SC725819 bus:Director1 2024-04-01 2025-03-31 SC725819 core:Goodwill 2024-04-01 2025-03-31 SC725819 core:PlantMachinery 2024-04-01 2025-03-31 SC725819 core:FurnitureFittings 2024-04-01 2025-03-31 SC725819 2023-04-01 2024-03-31 SC725819 core:NetGoodwill 2024-03-31 SC725819 core:NetGoodwill 2024-04-01 2025-03-31 SC725819 core:PlantMachinery 2024-03-31 SC725819 core:FurnitureFittings 2024-03-31 SC725819 2024-03-31 SC725819 bus:OrdinaryShareClass1 2024-04-01 2025-03-31 SC725819 bus:OrdinaryShareClass2 2024-04-01 2025-03-31 SC725819 bus:OrdinaryShareClass1 2025-03-31 SC725819 bus:OrdinaryShareClass1 2024-03-31 SC725819 bus:OrdinaryShareClass2 2025-03-31 SC725819 bus:OrdinaryShareClass2 2024-03-31 SC725819 bus:AllOrdinaryShares 2025-03-31 SC725819 bus:AllOrdinaryShares 2024-03-31 SC725819 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 SC725819 bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 SC725819 bus:FRS102 2024-04-01 2025-03-31 SC725819 bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 SC725819 bus:FullAccounts 2024-04-01 2025-03-31 xbrli:pure xbrli:shares iso4217:GBP